Jan 27, 2025 · We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries that defeat cancer. We discovered that DNA damage is the basic cause of cancer, laying the foundation ...

We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. As well as being a world-class research institute, the ICR is a higher education institution and a member institution of the University of London.We came second-top in the league table of university research quality, impact and environment compiled from the most recent Research ...

Training tomorrow’s leaders. The ICR is a higher education institution and a member institution of the University of London, providing PhD studentships and other higher level courses.We are committed to educating and training the next generation of researchers and clinicians.

Our achievements Characterising the BRAF gene Transforming prostate cancer treatment Advanced radiotherapy techniques Identifying a breast cancer gene Targeting Hsp90 How cells become cancerous The function of the thymus Practice changing clinical trials in radiotherapy and imaging DNA damage and cancer Identifying cancer predisposition genes Applying evolutionary biology to cancer ...

The REF assessed all higher education institutions (HEIs) in the UK which were eligible for public research funding. Our submission included world-class research studies on the development of PARP inhibitor drugs, the discovery and development of AKT inhibitor drugs, and the improvement of radiotherapy treatment for breast cancer and prostate cancer patients.

Aims, facilities and activity in this division . The division brings together a wide variety of disciplines, including cell and molecular biology, pharmacology, tumour modelling, computational and structural biology, and medicinal chemistry, in order to select promising drug targets, design effective prototype drugs and biomarkers, and develop strategies to counter drug resistance.

Our vision: We will transform the lives of cancer patients through world-class research and education, and by growing our impact on society. Cancer patients are living longer and with a better quality of life. Advances in our understanding of …

Clinical trials. The ICR Clinical Trials and Statistics Unit (ICR-CTSU) leads the design, conduct and analysis of phase II and III national and international cancer clinical trials. Our findings directly influence clinical practice within the NHS and worldwide. This page highlights recent news stories and blog posts that concern clinical trials that involve the ICR.

REF success. We came second in the Times Higher Education league table of university research quality, impact and environment compiled from the most recent Research Excellence Framework (REF 2021).. The ICR was ranked as best in biological sciences, and the third-leading higher education institution in the UK for the impact of our research …

Aims, facilities and activity in this division . The division includes the Cancer Research UK Radiation Research Centre of Excellence (RadNet), the Centre for Cancer Imaging, and overlaps with the Joint Department of Physics, which spans The Institute of Cancer Research, London, and The Royal Marsden NHS Foundation Trust.